Pro: Fresh versus frozen embryo transfer. Is frozen embryo transfer the future?

低温保存 胚胎移植 活产 怀孕 随机对照试验 玻璃化 胚胎冷冻保存 胚胎 更安全的 妊娠率 单胚胎移植 产科 医学 妇科 男科 生物 外科 计算机科学 细胞生物学 遗传学 计算机安全
作者
Christos A. Venetis
出处
期刊:Human Reproduction [Oxford University Press]
卷期号:37 (7): 1379-1387 被引量:5
标识
DOI:10.1093/humrep/deac126
摘要

Embryo cryopreservation has been an integral part of ART for close to 40 years and vitrification has boosted overall ART efficacy and safety. Recently, there has been a vivid scientific discussion on whether elective cryopreservation of all embryos (freeze-all) should be pursued for most patients, with a fresh embryo transfer taking place only in selected cases. In terms of efficacy, the available evidence suggests that the freeze-all strategy leads to higher live birth rates after the first embryo transfer compared to the conventional strategy in high responders, while there is no difference in normal responders. There is no evidence to suggest that the freeze-all strategy is inferior to the conventional strategy of fresh transfer when comparing cumulative live birth rates using data from all available randomized controlled trials. The incidence of ovarian hyperstimulation syndrome is significantly reduced in the freeze-all policy. However, regarding obstetric complications and neonatal outcomes, the evidence suggests that each strategy is associated with certain risks and, therefore, there is no approach that could be unequivocally accepted as safer. Similarly, limited evidence does not support the notion that patients would be universally against freeze-all owing to the inevitable delay in pregnancy achievement. Finally, the cost-effectiveness of freeze-all is likely to vary in different settings and there have been studies supporting that this policy can be, under certain conditions, cost-effective. Adoption of the freeze-all policy can also allow for more flexible treatment strategies that have the potential to increase efficacy, reduce cost and make treatment easier for patients and clinics. Importantly, freeze-all does not require the use of any experimental technologies, further training of personnel or the costly acquisition of new equipment. For these reasons, transitioning to the freeze-all policy for most patients appears to be the next logical step in ART.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
HMBB发布了新的文献求助10
1秒前
tk完成签到 ,获得积分10
1秒前
1秒前
李白发布了新的文献求助10
1秒前
gdh发布了新的文献求助10
1秒前
西贝子子完成签到,获得积分20
2秒前
3秒前
4秒前
珊熙完成签到,获得积分20
5秒前
chin发布了新的文献求助10
8秒前
ZY发布了新的文献求助10
9秒前
10秒前
共享精神应助科研通管家采纳,获得10
10秒前
烟花应助科研通管家采纳,获得10
10秒前
踏实天空应助科研通管家采纳,获得10
10秒前
科研通AI2S应助科研通管家采纳,获得10
10秒前
10秒前
11秒前
12秒前
12秒前
你好啊发布了新的文献求助10
15秒前
沐熙完成签到,获得积分10
15秒前
丘比特应助gdh采纳,获得10
17秒前
Majician完成签到,获得积分10
19秒前
19秒前
Akim应助失重心跳采纳,获得10
20秒前
NexusExplorer应助surain采纳,获得30
20秒前
拼搏的宇完成签到 ,获得积分10
21秒前
科目三应助啊啊啊lei采纳,获得10
21秒前
万能图书馆应助小武wwwww采纳,获得10
21秒前
22秒前
马马马发布了新的文献求助10
23秒前
bkagyin应助你好啊采纳,获得10
23秒前
在水一方应助huco采纳,获得10
25秒前
25秒前
慕青应助顾文强采纳,获得10
25秒前
26秒前
26秒前
28秒前
析界成微完成签到,获得积分10
29秒前
高分求助中
Kinetics of the Esterification Between 2-[(4-hydroxybutoxy)carbonyl] Benzoic Acid with 1,4-Butanediol: Tetrabutyl Orthotitanate as Catalyst 1000
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
Rechtsphilosophie 1000
Bayesian Models of Cognition:Reverse Engineering the Mind 888
Very-high-order BVD Schemes Using β-variable THINC Method 568
Chen Hansheng: China’s Last Romantic Revolutionary 500
XAFS for Everyone 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3137814
求助须知:如何正确求助?哪些是违规求助? 2788675
关于积分的说明 7788104
捐赠科研通 2445088
什么是DOI,文献DOI怎么找? 1300139
科研通“疑难数据库(出版商)”最低求助积分说明 625828
版权声明 601043